NVP-DKY70 demonstrates dose-dependent and selective degradation of IKZF2 (maximum degradation 69%, DC50 11 nM), while sparing IKZF1/3, in AML cell lines. The gene discussed is IKZF2; the disease is acute myeloid leukemia.